Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELIEF study of injectable diclofenac + thiocolchicoside for acute low back pain
2024-518753-42-00Phase 3Completed
- Sponsor
- Epifarma
- Start
- Nov 2024
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in lumbodynia (LBP) comparing Diclofenac + thiocolchicoside injection, Diclofenac active control injection and Placebo control injection (3 arms). Primary endpoint: SPID in pain at rest through Day 3. Started Nov 2024; status: completed.
02
Drugs
diclofenacthiocolchicoside
03
Conditions
lumbodynia (LBP)
Beyond the preview
Go deeper on 2024-518753-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518753-42-00.